At Clinical Labs, we provide leadership and diagnostic excellence across all of our specialities, and our commitment to skin pathology is no exception.
Clinical Labs provides a highly personalised, bespoke service through the development of strong consultative relationships with referrers – working together with you to provide the best possible care for your patients. Our dedicated skin pathology team have access to advanced testing technologies to assist in providing definitive diagnoses. Our dedicated team of experienced skin pathologists is focused on providing you with an exceptional skin pathology service. Inspiring you with trust and confidence, our team will go the extra mile to achieve the best diagnosis for your patients.
Sending patient skin samples to Clinical Labs for diagnosis will give you:
- Access to our specialised skin pathology team for all clinical enquiries
- Accurate, clear and consistent diagnostic reporting
- Personalised consultation for complex cases
- Regular and relevant clinical updates and informative resources
- Access to our RACGP-approved Skin Excision Evaluation Program
Below you will find a series of educational clinical articles, written by our expert skin pathologists, covering areas of skin disease including basal and squamous cell carcinomas, melanoma and inflammatory skin conditions. We hope you find this content valuable in your practice.
Suspicious Pigmented Skin Lesions - Melanoma and Dysplastic Naevi by Dr Jenny Grew and Dr Janez Cernelc
- Contains recommendations from the Cancer Council guidelines for the diagnosis and management of melanoma and the WHO Classification of Skin Tumours (2018).
- A Q&A between Clinical Labs Anatomical Pathologist Dr Gabriel Scripcaru and Skin Cancer Practitioner Dr Emily Shaw, designed to promote discussion between general practitioners and pathologists to optimise skin cancer management.
Accurate Diagnosis of Basal and Squamous Cell Carcinomas in General Practice by Dr Gabriel Scripcaru and Dr Predrag Nikolic
- Contains information on clinical and high-risk features, biopsy recommendations and management.
- Includes information on lichen planus, granuloma annulare, discoid lupus erythematosus, porokeratosis and Grover disease.
Skin Biopsy: Lesions and inflammation by Dr Jenny Grew
- Includes information on recommended biopsy type for non-pigmented discrete lesions, pigmented lesions, rashes/inflammatory conditions and alopecia.
Melanoma is a type of cancer with which Australian general practitioners are, unfortunately, all too familiar. Melanoma accounts for 75% of skin cancer deaths. According to the Melanoma Institute Australia, approximately 14,000 Australians are diagnosed with melanoma annually and more than 1,800 die from melanoma each year – that is five people a day.
Join thousands of general practitioners nationwide and register for our Skin Excision Evaluation Program today!
Our program offers you the support to evaluate your prognostic knowledge of skin cancer medicine and improve the health outcomes of your patients, while also earning Continuing Professional Development (CPD) points. The program aids skin cancer management for patients by improving the identification of high-risk lesions so they can be treated at an early stage.
As you progress through the program you can rely on our expert pathologists to give you accurate diagnostic assessments. You can contact our pathologists personally if you have any questions along the way.
For further information or to register today, CLICK on the buttons below.
Skin Excision Evaluation Program
Program Registration Form